{"transactions":[{"id":749471,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-04T21:25:20.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":223492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":223492,"derivative":{"exercise_price":1.58,"exercise_date":"2026-07-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":223492},"source":{"system":"sec-edgar","filing":"0001299130-26-000104","document":"wk-form4_1780608317.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000129913026000104/wk-form4_1780608317.xml","form_type":"4"}},{"id":1119480,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-06T20:06:03.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":32500,"derivative":{"exercise_price":1.03,"exercise_date":"2025-07-04","expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001299130-25-000131","document":"wk-form4_1749240357.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000129913025000131/wk-form4_1749240357.xml","form_type":"4"}},{"id":1247385,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-25T21:37:34.000Z","date":"2025-02-23","kind":"exercise","planned":false,"acquired":false,"shares":57413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 23, 2024, Mr. Smith was granted 172,239 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":114826,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":57413},"source":{"system":"sec-edgar","filing":"0001077183-25-000039","document":"wk-form4_1740519447.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000039/wk-form4_1740519447.xml","form_type":"4"}},{"id":1247384,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-25T21:37:34.000Z","date":"2025-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":14067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units."}],"balance_after":641585,"source":{"system":"sec-edgar","filing":"0001077183-25-000039","document":"wk-form4_1740519447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000039/wk-form4_1740519447.xml","form_type":"4"}},{"id":1247383,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-25T21:37:34.000Z","date":"2025-02-23","kind":"exercise","planned":false,"acquired":true,"shares":57413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting."}],"balance_after":655652,"source":{"system":"sec-edgar","filing":"0001077183-25-000039","document":"wk-form4_1740519447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000039/wk-form4_1740519447.xml","form_type":"4"}},{"id":1287262,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-04T00:22:21.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":72901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to the option will vest on January  30, 2026, which is the one year anniversary of Mr. Smith joining the Board, and the remainder will vest in equal monthly installments thereafter for 24 months on the same date of the month as his initial start date, provided he continues to serve as a director through each vesting date."}],"balance_after":72901,"derivative":{"exercise_price":1.6,"exercise_date":"2026-01-30","expiration_date":"2035-01-30","underlying":"Common Stock","underlying_shares":72901},"source":{"system":"sec-edgar","filing":"0001299130-25-000022","document":"wk-form4_1738628535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000129913025000022/wk-form4_1738628535.xml","form_type":"4"}},{"id":1287261,"issuer":{"id":5650,"kind":"organization","name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","symbol":"PACB"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T00:22:21.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":54099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Smith was elected to the Board of Directors on January 30, 2025. Each share is represented by a Restricted Stock Unit (\"RSU\"). The RSUs will vest in equal annual installments on January 30th of each of 2026, 2027, and 2028, provided such Reporting Person continues to serve as a director through the applicable vesting dates."}],"balance_after":54099,"source":{"system":"sec-edgar","filing":"0001299130-25-000022","document":"wk-form4_1738628535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000129913025000022/wk-form4_1738628535.xml","form_type":"4"}},{"id":1343591,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-04T21:09:06.000Z","date":"2024-05-11","kind":"exercise","planned":false,"acquired":false,"shares":48063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 11, 2023, Mr. Smith was granted 144,190 restricted stock units. These restricted stock units vest ratably over the first three year anniversary dates of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":96127,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":48063},"source":{"system":"sec-edgar","filing":"0001077183-24-000168","document":"wk-form4a_1733346539.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000168/wk-form4a_1733346539.xml","form_type":"4/A","original_submission_date":"2024-05-14"}},{"id":1343590,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-04T21:09:06.000Z","date":"2024-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":18913,"price":14.86,"value":281047.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On May 14, 2024, the reporting person filed a Form 4 which inadvertently reported the number of shares of common stock received upon the vesting of certain of his RSUs twice. In fact, as reported in this amendment, the reporting person directly owned 631,369 shares of common stock after the vesting of 48,063 RSUs and reported withholding. The error effected the number of shares reported in Column 5 of Table I of each of the reporting person's subsequent filings on Form 4."}],"balance_after":631369,"source":{"system":"sec-edgar","filing":"0001077183-24-000168","document":"wk-form4a_1733346539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000168/wk-form4a_1733346539.xml","form_type":"4/A","original_submission_date":"2024-05-14"}},{"id":1343589,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-04T21:09:06.000Z","date":"2024-05-11","kind":"exercise","planned":false,"acquired":true,"shares":48063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting."}],"balance_after":650282,"source":{"system":"sec-edgar","filing":"0001077183-24-000168","document":"wk-form4a_1733346539.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000168/wk-form4a_1733346539.xml","form_type":"4/A","original_submission_date":"2024-05-14"}},{"id":1429953,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-19T20:19:12.000Z","date":"2024-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":33130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the August 15, 2024 vesting of restricted stock."}],"balance_after":646302,"source":{"system":"sec-edgar","filing":"0001077183-24-000143","document":"wk-form4_1724098745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000143/wk-form4_1724098745.xml","form_type":"4"}},{"id":1518013,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-05-15T01:39:20.000Z","date":"2024-05-11","kind":"exercise","planned":false,"acquired":false,"shares":48063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 11, 2023, Mr. Smith was granted 144,190 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":96127,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":48063},"source":{"system":"sec-edgar","filing":"0001077183-24-000075","document":"wk-form4_1715737144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000075/wk-form4_1715737144.xml","form_type":"4"}},{"id":1518012,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-15T01:39:20.000Z","date":"2024-05-11","kind":"exercise","planned":false,"acquired":true,"shares":48063,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":679432,"source":{"system":"sec-edgar","filing":"0001077183-24-000075","document":"wk-form4_1715737144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000075/wk-form4_1715737144.xml","form_type":"4"}},{"id":1518011,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-15T01:39:20.000Z","date":"2024-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":18913,"price":14.86,"value":281047.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units."}],"balance_after":631369,"source":{"system":"sec-edgar","filing":"0001077183-24-000075","document":"wk-form4_1715737144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000075/wk-form4_1715737144.xml","form_type":"4"}},{"id":1518010,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-15T01:39:20.000Z","date":"2024-05-11","kind":"exercise","planned":false,"acquired":true,"shares":48063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting."}],"balance_after":650282,"source":{"system":"sec-edgar","filing":"0001077183-24-000075","document":"wk-form4_1715737144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000075/wk-form4_1715737144.xml","form_type":"4"}},{"id":1616834,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Unit","published_at":"2024-02-27T21:28:18.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":172240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On February 23, 2024, Mr. Smith was granted 172,240 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 258,360. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":172240,"derivative":{"exercise_price":0,"exercise_date":"2027-02-23","underlying":"Common Stock","underlying_shares":172240},"source":{"system":"sec-edgar","filing":"0001077183-24-000028","document":"wk-form4_1709069286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000028/wk-form4_1709069286.xml","form_type":"4"}},{"id":1616833,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-27T21:28:18.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":172239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On February 23, 2024, Mr. Smith was granted 172,239 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":172239,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":172239},"source":{"system":"sec-edgar","filing":"0001077183-24-000028","document":"wk-form4_1709069286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000028/wk-form4_1709069286.xml","form_type":"4"}},{"id":1616832,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option  (Right to Buy)","published_at":"2024-02-27T21:28:18.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":287940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On February 23, 2024, Mr. Smith was granted 287,940 stock options. These options vest ratably over the first three anniversary dates of the grant date."}],"balance_after":287940,"derivative":{"exercise_price":16.45,"expiration_date":"2034-02-23","underlying":"Common Stock","underlying_shares":287940},"source":{"system":"sec-edgar","filing":"0001077183-24-000028","document":"wk-form4_1709069286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000028/wk-form4_1709069286.xml","form_type":"4"}},{"id":1862129,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2023-06-08T20:29:36.000Z","date":"2023-06-06","kind":"exercise","planned":false,"acquired":false,"shares":2248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on June 6, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested on June 6, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2248},"source":{"system":"sec-edgar","filing":"0001209191-23-035401","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000120919123035401/doc4.xml","form_type":"4"}},{"id":1862128,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-08T20:29:36.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":2248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":2249,"source":{"system":"sec-edgar","filing":"0001209191-23-035401","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000120919123035401/doc4.xml","form_type":"4"}},{"id":1873265,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-31T20:05:11.000Z","date":"2023-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":1225,"price":85.54,"value":104786.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the  vesting of previously granted restricted stock awards."}],"balance_after":33329,"source":{"system":"sec-edgar","filing":"0001209191-23-033101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000120919123033101/doc4.xml","form_type":"4"}},{"id":1877956,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Premium)","published_at":"2023-05-26T00:21:53.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":80,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on May 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on May 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."}],"balance_after":80,"derivative":{"underlying":"Common Stock","underlying_shares":80},"source":{"system":"sec-edgar","filing":"0001209191-23-032333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000120919123032333/doc4.xml","form_type":"4"}},{"id":1877955,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Converted)","published_at":"2023-05-26T00:21:53.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest on the date of the grant, May 24, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest on the date of the grant, May 24, 2023."}],"balance_after":402,"derivative":{"underlying":"Common Stock","underlying_shares":402},"source":{"system":"sec-edgar","filing":"0001209191-23-032333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000120919123032333/doc4.xml","form_type":"4"}},{"id":1877954,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2023-05-26T00:21:53.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":2416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on May 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on May 24, 2024."}],"balance_after":2416,"derivative":{"underlying":"Common Stock","underlying_shares":2416},"source":{"system":"sec-edgar","filing":"0001209191-23-032333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000120919123032333/doc4.xml","form_type":"4"}},{"id":1893979,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Unit","published_at":"2023-05-15T21:07:00.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":144190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On May 11, 2023, Mr. Smith was granted 144,190 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 216,285. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":144190,"derivative":{"exercise_price":0,"exercise_date":"2026-05-11","underlying":"Common Stock","underlying_shares":144190},"source":{"system":"sec-edgar","filing":"0001077183-23-000054","document":"wf-form4_168418480755854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000054/wf-form4_168418480755854.xml","form_type":"4"}},{"id":1893978,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-05-15T21:07:00.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":144190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 11, 2023, Mr. Smith was granted 144,190 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":144190,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":144190},"source":{"system":"sec-edgar","filing":"0001077183-23-000054","document":"wf-form4_168418480755854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000054/wf-form4_168418480755854.xml","form_type":"4"}},{"id":1893977,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-15T21:07:00.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":269841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 11, 2023, Mr. Smith was granted 269,841 stock options. These options vest ratably over the first three anniversary dates of the grant date."}],"balance_after":269841,"derivative":{"exercise_price":19.65,"expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":269841},"source":{"system":"sec-edgar","filing":"0001077183-23-000054","document":"wf-form4_168418480755854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000054/wf-form4_168418480755854.xml","form_type":"4"}},{"id":2182450,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-17T23:13:39.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":694444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 15, 2022, Mr. Smith was granted 694,444 stock options. These options vest ratably over the first four anniversary dates of the grant date."}],"balance_after":694444,"derivative":{"exercise_price":12.62,"expiration_date":"2029-08-15","underlying":"Common Stock","underlying_shares":694444},"source":{"system":"sec-edgar","filing":"0001077183-22-000148","document":"wf-form4_166077800532643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000148/wf-form4_166077800532643.xml","form_type":"4"}},{"id":2182449,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-17T23:13:39.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":265452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On August 15, 2022, Mr. Smith was granted 265,452 restricted stock awards. These awards vest on the fourth anniversary date of the grant date."}],"balance_after":602219,"source":{"system":"sec-edgar","filing":"0001077183-22-000148","document":"wf-form4_166077800532643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000148/wf-form4_166077800532643.xml","form_type":"4"}},{"id":2182448,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-17T23:13:39.000Z","date":"2022-08-15","kind":"grant","acquired":true,"shares":336767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 15, 2022, Mr. Smith was granted 336,767 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date."}],"balance_after":336767,"source":{"system":"sec-edgar","filing":"0001077183-22-000148","document":"wf-form4_166077800532643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000148/wf-form4_166077800532643.xml","form_type":"4"}},{"id":2199037,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-01T23:17:49.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":34554,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The Form 4 originally filed on June 1, 2022 is being amended to correct the vesting schedule with respect to 29,418 restricted stock awards held by the reporting person."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc (\"Ortho\"), QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc., and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc (\"Ortho\"), QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc., and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 29,418 restricted stock awards, of which 4,203 shares vested on July 28, 2022, 16,811 shares will vest on September 9, 2022, 4,201 shares will vest on February 28, 2023 and 4,203 shares will vest on May 27, 2023."}],"balance_after":34554,"source":{"system":"sec-edgar","filing":"0001209191-22-043762","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000120919122043762/doc4a.xml","form_type":"4/A","original_submission_date":"2022-06-01"}},{"id":2221182,"issuer":{"id":11574,"kind":"organization","name":"Akouos, Inc.","symbol":"AKUS"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-27T17:05:05.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 23, 2022. The shares underlying the option will fully vest on the earlier of (i) June 23, 2023 and (ii) the date of the Issuer's 2023 annual meeting of stockholders."}],"balance_after":16000,"derivative":{"exercise_price":4.21,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001104659-22-074831","document":"tm2219359-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722271/000110465922074831/tm2219359-5_4seq1.xml","form_type":"4"}},{"id":2239009,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2022-06-08T22:20:20.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":2248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on June 6, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on June 6, 2023."}],"balance_after":2248,"derivative":{"underlying":"Common Stock","underlying_shares":2248},"source":{"system":"sec-edgar","filing":"0001209191-22-035179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000120919122035179/doc4.xml","form_type":"4"}},{"id":2249422,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-06-01T21:30:00.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":207984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Business Combination Agreement, each Ortho stock option was converted into an equal number of Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vested in full."}],"balance_after":207984,"derivative":{"exercise_price":119.06,"expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":207984},"source":{"system":"sec-edgar","filing":"0000899243-22-020478","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000089924322020478/doc4.xml","form_type":"4"}},{"id":2249421,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-01T21:30:00.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":34554,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc (\"Ortho\"), QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc (\"Ortho\"), QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 29,418 restricted stock awards, of which 2,101 shares will vest on July 28, 2022, 8,404 shares will vest on September 9, 2022, 2,100 shares will vest on February 28, 2023 and 8,406 shares will vest on May 27, 2023."}],"balance_after":34554,"source":{"system":"sec-edgar","filing":"0000899243-22-020478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000089924322020478/doc4.xml","form_type":"4"}},{"id":2249419,"issuer":{"id":126680,"kind":"organization","name":"Ortho Clinical Diagnostics Holdings plc","symbol":"OCDX"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Stock Option","published_at":"2022-06-01T20:15:42.000Z","date":"2022-05-27","kind":"disposition_to_issuer","acquired":false,"shares":1971420,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each stock option, whether vested or unvested, was converted into (a) a Coronado Topco stock option on the same terms and conditions as were applicable to such stock option immediately prior to the Effective Time, except as adjusted by the BCA, (b) with respect to the portion of such stock option that is vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the vested portion of such stock option and (c) with respect to the portion of such stock option that is not vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the unvested portion of such stock option when it vests in accordance with its terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the Effective Time, each stock option, whether vested or unvested, was converted into (a) a Coronado Topco stock option on the same terms and conditions as were applicable to such stock option immediately prior to the Effective Time, except as adjusted by the BCA, (b) with respect to the portion of such stock option that is vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the vested portion of such stock option and (c) with respect to the portion of such stock option that is not vested as of the Effective Time, the right to receive payment, in cash, equal to the cash consideration payable in respect of the Issuer's securities subject to the unvested portion of such stock option when it vests in accordance with its terms."}],"balance_after":0,"derivative":{"exercise_price":12.56,"expiration_date":"2029-12-20","underlying":"Ordinary Shares, $0.00001 par value","underlying_shares":1971420},"source":{"system":"sec-edgar","filing":"0000899243-22-020381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000089924322020381/doc4.xml","form_type":"4"}},{"id":2249418,"issuer":{"id":126680,"kind":"organization","name":"Ortho Clinical Diagnostics Holdings plc","symbol":"OCDX"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Ordinary Shares, $0.00001 par value","published_at":"2022-06-01T20:15:42.000Z","date":"2022-05-27","kind":"disposition_to_issuer","acquired":false,"shares":367360,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Business Combination Agreement, dated December 22, 2021 (the \"BCA\"), by and among Coronado Topco, Inc. (\"Coronado Topco\"), Laguna Merger Sub, Inc., Orca Holdco, Inc., Orca Holdco 2, Inc., Quidel Corporation and the Issuer, the Issuer became a wholly owned subsidiary of Coronado Topco upon consummation of the business combinations (the \"Effective Time\"). At the Effective Time, each of the Issuer's ordinary shares was automatically converted into the right to receive (i) 0.1055 shares of common stock of Coronado Topco and (ii) $7.14 in cash."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-020381","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000089924322020381/doc4.xml","form_type":"4"}},{"id":2443673,"issuer":{"id":126680,"kind":"organization","name":"Ortho Clinical Diagnostics Holdings plc","symbol":"OCDX"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Stock Option","published_at":"2022-01-05T21:23:58.000Z","date":"2022-01-03","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in three equal annual installments beginning on September 9, 2020."}],"balance_after":935710,"derivative":{"exercise_price":12.56,"expiration_date":"2029-12-20","underlying":"Ordinary Shares, $0.00001 par value","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-22-001678","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000120919122001678/doc4.xml","form_type":"4"}},{"id":2443672,"issuer":{"id":126680,"kind":"organization","name":"Ortho Clinical Diagnostics Holdings plc","symbol":"OCDX"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Ordinary Shares, $0.00001 par value","published_at":"2022-01-05T21:23:58.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":100000,"price":21.098,"value":2109800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price for the price increments ranging from $21.0000 to $21.4000"}],"balance_after":367360,"source":{"system":"sec-edgar","filing":"0001209191-22-001678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000120919122001678/doc4.xml","form_type":"4"}},{"id":2443671,"issuer":{"id":126680,"kind":"organization","name":"Ortho Clinical Diagnostics Holdings plc","symbol":"OCDX"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Ordinary Shares, $0.00001 par value","published_at":"2022-01-05T21:23:58.000Z","date":"2022-01-03","kind":"exercise","acquired":true,"shares":100000,"price":12.56,"value":1256000.0,"ownership":{"direct":true},"balance_after":467360,"source":{"system":"sec-edgar","filing":"0001209191-22-001678","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000120919122001678/doc4.xml","form_type":"4"}},{"id":2614718,"issuer":{"id":126680,"kind":"organization","name":"Ortho Clinical Diagnostics Holdings plc","symbol":"OCDX"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Ordinary Shares, $0.00001 par value","published_at":"2021-08-04T22:29:01.000Z","date":"2021-08-04","kind":"sale","acquired":false,"shares":61800,"price":21.79,"value":1346622.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sales price for the price increments from $21.57 to $21.92."}],"balance_after":367360,"source":{"system":"sec-edgar","filing":"0001209191-21-049757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000120919121049757/doc4.xml","form_type":"4"}},{"id":2614717,"issuer":{"id":126680,"kind":"organization","name":"Ortho Clinical Diagnostics Holdings plc","symbol":"OCDX"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Ordinary Shares, $0.00001 par value","published_at":"2021-08-04T22:29:01.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":104987,"price":21.5534,"value":2262826.8058,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price for the price increments from $21.00 to $21.90."}],"balance_after":429160,"source":{"system":"sec-edgar","filing":"0001209191-21-049757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000120919121049757/doc4.xml","form_type":"4"}},{"id":2614716,"issuer":{"id":126680,"kind":"organization","name":"Ortho Clinical Diagnostics Holdings plc","symbol":"OCDX"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Ordinary Shares, $0.00001 par value","published_at":"2021-08-04T22:29:01.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":103213,"price":22.1003,"value":2281038.2639,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price for the price increments from $21.90 to $22.51."}],"balance_after":534147,"source":{"system":"sec-edgar","filing":"0001209191-21-049757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1436707/000120919121049757/doc4.xml","form_type":"4"}},{"id":2654828,"issuer":{"id":11574,"kind":"organization","name":"Akouos, Inc.","symbol":"AKUS"},"owners":[{"id":41324,"kind":"person","name":"Smith Christopher M","position":1,"cik":"0001436707","reported_name":"Smith Christopher M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-25T16:35:13.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 24, 2021. The shares underlying the option will fully vest on the earlier of (i) June 24, 2022 and (ii) the date of the Issuer's 2022 annual meeting of stockholders."}],"balance_after":16000,"derivative":{"exercise_price":13.39,"expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001104659-21-085756","document":"tm2120686-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722271/000110465921085756/tm2120686-2_4seq1.xml","form_type":"4"}}]}